A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus

NCT04050553 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Hypoglycemia

Interventions

DRUG: Tirzepatide
DRUG: Placebo

Sponsor

Eli Lilly and Company